Detlev Biniszkiewicz
Founder and CEO of NextPoint Therapeutics, advancing the field of immuno-oncology through scientific work on the novel HHLA2 pathway.
Best podcasts with Detlev Biniszkiewicz
Ranked by the Snipd community
Jun 7, 2023 • 34min
BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx
Detlev Biniszkiewicz, Founder & CEO of NextPoint Therapeutics, discusses the challenges and opportunities in immuno-oncology, team building, and the current biotech environment. He shares the founding story of NextPoint and their focus on targeting the A to LA2 receptor for immune therapy. The chapter also explores the challenges of transitioning from preclinical to clinical stages, securing funding, and the speaker's rapid career growth.
